Conquering lung cancer: current status and prospects for the future by Pirker, R.

Get full text

Hyperprogression of Merkel cell carcinoma after avelumab treatment by Pirker, R., Fink, A., Stella, A., Stifter, L., Posch, C.

Get full text

New onset of systemic lupus erythematosus following COVID‐19 mRNA vaccination by Hansen, E., Feldmann, R., Pirker, R., Jochmann, J., Breier, F., Posch, C.

Get full text

SP-0759: Immunotherapy approaches to advanced lung cancer by Pirker, R.

Get full text

JICC01.07 Oral VEGFR Inhibitor Monotherapy for Lung Cancer: Should We or Should We Not? by Pirker, R.

Get full text

PC05.03 ICIs for Patients with Immune-Related Comorbidity by Pirker, R.

Get full text

Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients by Reitter, E.‐M., Ay, C., Kaider, A., Pirker, R., Zielinski, C., Zlabinger, G., Pabinger, I.

Get full text

10IN ADJUVANT CHEMOTHERAPY IN STAGE IB by Pirker, R

Get full text

41IN ENDPOINTS IN CLINICAL TRIALS by Pirker, R

Get full text

MS 20.02 Value-Based Judgment in Advanced NSCLC: The European Perspective by Pirker, R.

Get full text

3109 nab-Paclitaxel (nab-P) plus carboplatin (C) as first-line treatment in patients with advanced non-small cell lung cancer (NSCLC): Clinical outcomes by treatment cycle by Gridelli, C, Li, L, O'Brien, M, Ong, T.J, Pirker, R, Socinski, M.A, Thomas, M

Get full text

Prognostic factors in patients with advanced non-small cell lung cancer: Data from the phase III FLEX study by Pirker, R, Pereira, J.R, Szczesna, A, von Pawel, J, Krzakowski, M, Ramlau, R, Vynnychenko, I, Park, K, Eberhardt, W.E.E, de Marinis, F, Heeger, S, Goddemeier, T, O’Byrne, K.J, Gatzemeier, U

Get full text

Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient by Pircher, A, Manzl, C, Fiegl, M, Popper, H, Pirker, R, Hilbe, W

Get full text

High D-dimer levels are associated with poor prognosis in cancer patients by AY, Cihan, DUNKLER, Daniela, PIRKER, Robert, THALER, Johannes, QUEHENBERGER, Peter, WAGNER, Oswald, ZIELINSKI, Christoph, PABINGER, Ingrid

Get full text

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop by Pirker, Robert, Herth, Felix J.F., Kerr, Keith M., Filipits, Martin, Taron, Miquel, Gandara, David, Hirsch, Fred R., Grunenwald, Dominique, Popper, Helmut, Smit, Egbert, Dietel, Manfred, Marchetti, Antonio, Manegold, Christian, Schirmacher, Peter, Thomas, Michael, Rosell, Rafael, Cappuzzo, Federico, Stahel, Rolf

Get full text

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial by Pirker, Robert, Prof, Pereira, Jose R, MD, Szczesna, Aleksandra, MD, von Pawel, Joachim, MD, Krzakowski, Maciej, Prof, Ramlau, Rodryg, MD, Vynnychenko, Ihor, MD, Park, Keunchil, Prof, Yu, Chih-Teng, MD, Ganul, Valentyn, Prof, Roh, Jae-Kyung, Prof, Bajetta, Emilio, Prof, O'Byrne, Kenneth, Prof, de Marinis, Filippo, MD, Eberhardt, Wilfried, MD, Goddemeier, Thomas, Dipl Stat, Emig, Michael, MD, Gatzemeier, Ulrich, MD

Get full text

Simultaneous determination of gentisic, salicyluric and salicylic acid in human plasma using solid-phase extraction, liquid chromatography and electrospray ionization mass spectrom... by PIRKER, R, HUCK, C. W, POPP, M, BONN, G. K

Get full text

Simultaneous determination of gentisic, salicyluric and salicylic acid in human plasma using solid-phase extraction, liquid chromatography and electrospray ionization mass spectrom... by Pirker, R., Huck, C.W., Popp, M., Bonn, G.K.

Get full text

9000 ORAL Epidermal Growth Factor Receptor (EGFR) Expression as a Predictive Biomarker of Survival in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving First-Line... by O'Bvrne, K, Paz-Ares, L, Pereira, J.R, von Pawel, J, Ramlau, R, Störkel, S, Schumacher, K.M, von Heydebreck, A, Celik, I, Pirker, R

Get full text

Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline by Vansteenkiste, J, Tomita, D, Rossi, G, Pirker, R

Get full text